Amazon Bio Discovery develops three AI approaches for antibody drug design
Amazon Science said Amazon Bio Discovery developed MochiBind, CA-MAP, and an agent-guided design system to accelerate antibody drug design, reporting 46 lab-validated hits against a novel cancer target.